SOURCE: Quanticate

Quanticate

October 26, 2009 08:30 ET

Global Biometrics Clinical and Research Organization Quanticate Appoints Scott W. Clark as Head of Business Development for North America

CAMBRIDGE, MA and LONDON--(Marketwire - October 26, 2009) - Quanticate, a global biometrics clinical research organization (CRO), today announced that it has appointed Scott W. Clark as Head of Business Development Americas for its clinical trials services and operations headquartered in Cambridge, MA. The appointment enhances the company's mission to further expand its clinical trial service capabilities with Clark managing the company's North American Business Development initiatives in support of existing and new clients.

"Scott's appointment is strategically important to the continual development of our rapidly growing North American business," said Quanticate's US President Andrew MacGarvey. "Scott brings considerable success, knowledge and experience in developing new markets and operational management to our expanding team. He uniquely brings a deep understanding of both the pharmaceutical companies' methodologies from the commercial and clinical areas combined with extensive knowledge and experience in applying the CRO approach to solving their critical needs."

Prior to joining Quanticate, Clark served as VP and Global Head of Quintiles eSolutions Business, a web development and eservices unit for the commercial and clinical trial and research community. Clark worked in a developmental, operational and commercial capacity, helping the company to expand its service offerings and launch its clinical trial services into the global market. His experience includes executive level positions in sales, marketing, technology and operations at Pfizer, SmithKline Beecham, & Premier Inc.

MacGarvey believes the appointment of Clark will be instrumental in driving the growing CRO market for Quanticate's services in the US and Canada. "Scott has an excellent reputation in the industry and we are very happy to have him join Quanticate. This is part of an overarching plan to recruit top talent within our organization. Much of our anticipated growth will be from US companies conducting multiple phases of clinical trials here and overseas. Scott brings a significant consultative experience and understanding of our business that will be critical to developing new markets."

About Quanticate

Quanticate, with headquarters in Cambridge, MA and London, UK, is the largest global biometrics company with full service clinical trial capabilities. Trusted and respected throughout the industry, Quanticate delivers premium quality clinical trial services, consultancy, highly scalable on- and off-site data management, statistical programming and analysis, and medical writing solutions. Dedicated staff recruitment services are provided through Quanticate People. With resources spanning three continents, Quanticate is renowned for its dedication to clients, world-class service and superior results. In working closely with biotech, pharmaceutical and medical device companies, Quanticate prides itself in being a seamless extension of its customers' internal teams offering the flexibility to adapt to any technology environment. For more information, visit www.quanticate.com.

Contact Information

  • Media Contact
    Valerie Harding
    Ripple Effect Communications
    617-536-8887
    Email Contact